The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Novotnij D.A.

City Clinical No.1

Zhukova N.G.

Siberian State Medical University

Shperling L.P.

Regional Center for Extrapyramidal Diseases with Botulinum Therapy Room

Stolyarova V.A.

Siberian State Medical University

Zhukova I.A.

Siberian State Medical University

Agasheva A.E.

Siberian State Medical University

Shtaimets S.V.

City clinic No 3 of the Omsk region

Druzhinina O.A.

City Polyclinic No. 1

Shirokikh I.V.

Tsivyan Novosibirsk Research Institute of Traumatology and Orthopedics

Vitamin D and other indicators of calcium-phosphorus metabolism as possible predictors of Parkinson’s disease

Authors:

Novotnij D.A., Zhukova N.G., Shperling L.P., Stolyarova V.A., Zhukova I.A., Agasheva A.E., Shtaimets S.V., Druzhinina O.A., Shirokikh I.V.

More about the authors

Read: 3688 times


To cite this article:

Novotnij DA, Zhukova NG, Shperling LP, et al. . Vitamin D and other indicators of calcium-phosphorus metabolism as possible predictors of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(8):56‑64. (In Russ.)
https://doi.org/10.17116/jnevro202212208156

Recommended articles:
Diagnosis and treatment approaches for sialorrhea in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):29-34
Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Bladder dysfunction in patients with stages I—III of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):91-99
A portrait of a doctor with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):160-164
Vita­min D role in oral cavity diseases. Stomatology. 2025;(1):81-86
Economic issues of medi­cal care for hype­rparathyroidism. Part 1. Primary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):51-61

References:

  1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266‐281.  https://doi.org/10.1056/NEJMra070553
  2. Evatt ML, DeLong MR, Khazai N, et al. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008;65:1348‐1352. https://doi.org/10.1001/archneur.65.10.1348
  3. Lorefält B, Toss G, Granérus AK. Bone mass in elderly patients with Parkinson’s disease. Acta Neurol Scand. 2007;116:248‐254.  https://doi.org/10.1111/j.1600-0404.2007.00875.x
  4. Newmark HL, Newmark J. Vitamin D and Parkinson’s disease — a hypothesis. Mov Disord. 2007;22:461‐22:4.  https://doi.org/10.1002/mds.21317
  5. Martignoni E, Godi L, Citterio A. Comorbid disorders and hospitalization in Parkinson’s disease: a prospective study. Neurol Sci. 2004;25:66‐71.  https://doi.org/10.1007/s10072-004-0232-5
  6. Evatt ML, DeLong MR, Kumari M. High prevalence of hypovitaminosis D status in patients with early Parkinson disease. Arch Neurol. 2011;68:314‐319.  https://doi.org/10.1001/archneurol.2011.30
  7. Ding H, Dhima K, Lockhart KC, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 2013;81:1531‐1537. https://doi.org/10.1212/WNL.0b013e3182a95818
  8. Suzuki M, Yoshioka M, Hashimoto M. Randomized, doubleblind, placebo‐controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr. 2013;97:1004‐1013. https://doi.org/10.3945/ajcn.112.051664
  9. Shrestha S, Lutsey PL, Alonso A, et al. Serum 25‐hydroxyvitamin D concentrations in Mid‐adulthood and Parkinson’s disease risk. Mov Disord. 2016;31:972‐978.  https://doi.org/10.1002/mds.26573
  10. Peterson AL, Murchison C, Zabetian C. Memory, mood, and vitamin D in persons with Parkinson’s disease. J Parkinsons Dis. 2013;3:547‐555.  https://doi.org/10.3233/JPD-130206
  11. Kwon KY, Jo KD, Lee MK. Low serum vitamin D levels may contribute to gastric dysmotility in de novo Parkinson’s Disease. Neurodegener Dis. 2016;16:199‐205.  https://doi.org/10.1159/000441917
  12. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. JNNP. 1992;55:181-184.  https://doi.org/10.1136/jnnp.55.3.181
  13. Martínez-Martín P, Rodríguez-Blázquez C, Alvarez M, et al. Parkinson’s disease severity levels and MDS-Unified Parkinson’s Disease Rating Scale. Parkinsonism Relat Disord. 2015;21(1):50-54.  https://doi.org/10.1016/j.parkreldis.2014.10.026
  14. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. Journal of the American Geriatrics Society. 2005;53:695-699.  https://doi.org/10.1111/j.1532-5415.2005.53221.x
  15. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67(6):361-370.  https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
  16. Beck AT, Ward C, Mendelson M. Beck Depression Inventory (BDI). Arch Gen Psychiatry. 1961;4(6):561-571.  https://doi.org/10.1001/archpsyc.1961.01710120031004
  17. Holick MF, Binkley NC, Bischoff-Ferrari HA. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 96(7):1911-1930. https://doi.org/10.1210/jc.2011-0385
  18. Melnichenko GA, Belaya ZhE, Rozhinskaya LY. Federal clinical recommendations of diagnostic, treatment and osteoporosis prevention. Problemy Endokrinologii. 2017;63(6):392-426. (In Russ.). https://doi.org/10.14341/probl2017636392-426
  19. Lartey StT, Magnussen CG, Si L, et al. The role of intergenerational educational mobility and household wealth in adult obesity: Evidence from Wave 2 of the World Health Organization’s Study on global AGEing and adult health. PLOS ONE. 2019;14(1):e0208491. https://doi.org/10.1371/journal.pone.0208491
  20. Belinda B, Peat J. Medical statistics: a guide to SPSS, data analysis, and critical appraisal (2nd edition), Wiley, UK. 2014.
  21. Geng J, Zhang J, Yao F, et al. A systematic review and meta‐analysis of the associations of vitamin D receptor genetic variants with two types of most common neurodegenerative disorders. Aging Clin Exp Res. 2019;12(6):23-29.  https://doi.org/10.1007/s40520-019-01135-4
  22. Krisanova N, Pozdnyakova N, Pastukhov A. Vitamin D3 deficiency in puberty rats causes presynaptic malfunctioning through alterations in exocytotic release and uptake of glutamate/GABA and expression of EAAC‐1/GAT‐3 transporters. Food Chem Toxicol. 2019;123:123‐142.  https://doi.org/10.1016/j.fct.2018.10.054
  23. Rimmelzwaan LM, van Schoor NM, Lips P, et al. Systematic review of the relationship between vitamin D and Parkinson’s Disease. J Parkinsons Dis. 2016;6:29‐37.  https://doi.org/10.3233/JPD-150615
  24. Calvello R, Cianciulli A, Nicolardi G, et al. Vitamin D treatment attenuates neuroinflammation and dopaminergic neurodegeneration in an animal model of Parkinson’s disease, shifting M1 to M2 microglia responses. J Neuroimmune Pharmacol. 2017;12:327‐339.21.  https://doi.org/10.1007/s11481-016-9720-7
  25. Lima LAR, Lopes MJP, Costa RO, et al. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats. J Neuroinflammation. 2018;15:249.  https://doi.org/10.1186/s12974-018-1266-6
  26. Yeshokumar AK, Saylor D, Kornberg MD, et al. Evidence for the importance of vitamin D status in neurologic conditions. Curr Treat Options Neurol. 2015;17:51.  https://doi.org/10.1007/s11940-015-0380-3
  27. Dean ED, Mexas LM, Cápiro NL, et al. 25‐Hydroxyvitamin D depletion does not exacerbate MPTP‐induced dopamine neuron damage in mice. PLoS ONE. 2012;7:e39227. https://doi.org/10.1371/journal.pone.0039227
  28. Knekt P, Kilkkinen A, Rissanen H, et al. Serum vitamin D and the risk of Parkinson disease. Arch Neurol. 2010;67:808‐811.  https://doi.org/10.1001/archneurol.2010.120
  29. Anderson C, Checkoway H, Franklin GM, et al. Dietary factors in Parkinson’s disease: the role of food groups and specific foods. Mov Disord. 1999;14:21‐27. https://doi.org/10.1002/1531-8257(199901)14:1<21::aid-mds1006>3.0.co;2-y "> 3.0.co;2-y" target="_blank">https://doi.org/10.1002/1531-8257(199901)14:1<21::aid-mds1006>3.0.co;2-y
  30. Betemps EJ, Buncher CR. Birthplace as a risk factor in motor neurone disease and Parkinson’s disease. Int J Epidemiol. 1993;22:898‐904.  https://doi.org/10.1093/ije/22.5.898
  31. Lux WE, Kurtzke JF. Is Parkinson’s disease acquired? Evidence from a geographic comparison with multiple sclerosis. Neurology. 1987;37:467‐471.  https://doi.org/10.1212/wnl.37.3.467
  32. Lilienfeld DE, Sekkor D, Simpson S, et al. Parkinsonism death rates by race, sex and geography: a 1980s update. Neuroepidemiology. 1990;9:243‐247.  https://doi.org/10.1159/000110780
  33. Lanska DJ. The geographic distribution of Parkinson’s disease mortality in the United States. J Neurol Sci. 1997;150:63‐150.  https://doi.org/10.1016/s0022-510x(97)05371-9
  34. Van den Bos F, Speelman AD, Samson M, et al. Parkinson’s disease and osteoporosis. Age Ageing. 2013;42:156‐162.  https://doi.org/10.1093/ageing/afs161
  35. Bener A, Saleh NM. Low vitamin D, and bone mineral density with depressive symptoms burden in menopausal and postmenopausal women. J Midlife Health. 2015;6:108‐114.  https://doi.org/10.4103/0976-7800.165590
  36. Li S, Ou Y, Zhang H, et al. Vitamin D status and its relationship with body composition, bone mineral density and fracture risk in urban central south Chinese postmenopausal women. Ann Nutr Metab. 2014;64:13‐19.  https://doi.org/10.1159/000358340
  37. Zhao J‐G, Zeng X‐T, Wang J, Liu L. Association between calcium or vitamin D supplementation and fracture incidence in community dwelling older adults: a systematic review and meta‐analysis. JAMA. 2017;318:2466‐2482. https://doi.org/10.1001/jama.2017.19344
  38. Kruavit A, Chailurkit L‐O, Thakkinstian A, et al. Prevalence of vitamin D insufficiency and low bone mineral density in elderly Thai nursing home residents. BMC Geriatr. 2012;12:49.  https://doi.org/10.1186/1471-2318-12-49
  39. Hoang MT, DeFina LF, Willis BL, et al. Association between low serum 25‐hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc. 2011;86:1050‐1055. https://doi.org/10.4065/mcp.2011.0208
  40. Chao YS, Ekwaru JP, Ohinmaa A, et al. Vitamin D and health‐related quality of life in a community sample of older Canadians. Qual Life Res. 2014;23:2569‐23:25.  https://doi.org/10.1007/s11136-014-0696-6
  41. Peterson AL, Mancini M, Horak FB. The relationship between balance control and vitamin D in Parkinson’s disease‐a pilot study. Mov Disord. 2013;28:1133‐1137.14.  https://doi.org/10.1002/mds.25405
  42. Petersen MS, Bech S, Christiansen DH, et al. The role of vitamin D levels and vitamin D receptor polymorphism on Parkinson’s disease in the Faroe Islands. Neurosci Lett. 2014;561:74‐79.  https://doi.org/10.1016/j.neulet.2013.12.053
  43. Jang W, Park J, Kim JS, et al. Vitamin D deficiency in Parkinson’s disease patients with orthostatic hypotension. Acta Neurol Scand. 2015;132:242‐250.  https://doi.org/10.1111/ane.12390
  44. Armstrong DJ, Meenagh GK, Bickle I, et al. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol. 2007;26:551‐554.  https://doi.org/10.1007/s10067-006-0348-5

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.